TNF and obesity disorder: From a pharmacological point of view, the intestinal lipase inhibitor orlistat is of particular interest, which helps in weight reduction by decreasing levels of tumor necrosis factor alpha and interleukin 6 [22] and may reduce the risk of obesity and CVD [23, 24].